Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 140 entries
Sorted by: Best Match Show Resources per page
Neoadjuvant olaparib targets hypoxia to improve radioresponse in a homologous recombination-proficient breast cancer model.

Oncotarget

Borst GR, Kumareswaran R, Yücel H, Telli S, Do T, McKee T, Zafarana G, Jonkers J, Verheij M, O'Connor MJ, Rottenberg S, Bristow RG.
PMID: 29152107
Oncotarget. 2017 Sep 15;8(50):87638-87646. doi: 10.18632/oncotarget.20936. eCollection 2017 Oct 20.

Clinical trials are studying the benefits of combining the PARP-1 inhibitor olaparib with chemotherapy and radiotherapy treatment in a variety of cancer increasing the therapeutic ratio for olaparib may come from its ability to modify the tumour microenvironment by...

Cite
Borst GR, Kumareswaran R, Yücel H, et al. Neoadjuvant olaparib targets hypoxia to improve radioresponse in a homologous recombination-proficient breast cancer model. Oncotarget. 2017;8(50):87638-87646doi: 10.18632/oncotarget.20936.
Borst, G. R., Kumareswaran, R., Yücel, H., Telli, S., Do, T., McKee, T., Zafarana, G., Jonkers, J., Verheij, M., O'Connor, M. J., Rottenberg, S., & Bristow, R. G. (2017). Neoadjuvant olaparib targets hypoxia to improve radioresponse in a homologous recombination-proficient breast cancer model. Oncotarget, 8(50), 87638-87646. https://doi.org/10.18632/oncotarget.20936
Borst, Gerben R, et al. "Neoadjuvant olaparib targets hypoxia to improve radioresponse in a homologous recombination-proficient breast cancer model." Oncotarget vol. 8,50 (2017): 87638-87646. doi: https://doi.org/10.18632/oncotarget.20936
Borst GR, Kumareswaran R, Yücel H, Telli S, Do T, McKee T, Zafarana G, Jonkers J, Verheij M, O'Connor MJ, Rottenberg S, Bristow RG. Neoadjuvant olaparib targets hypoxia to improve radioresponse in a homologous recombination-proficient breast cancer model. Oncotarget. 2017 Sep 15;8(50):87638-87646. doi: 10.18632/oncotarget.20936. eCollection 2017 Oct 20. PMID: 29152107; PMCID: PMC5675659.
Copy Download .nbib Format: NLM
Congenital Short Bowel Syndrome: from clinical and genetic diagnosis to the molecular mechanisms involved in intestinal elongation.

Biochimica et biophysica acta

van der Werf CS, Halim D, Verheij JB, Alves MM, Hofstra RM.
PMID: 26282049
Biochim Biophys Acta. 2015 Nov;1852(11):2352-61. doi: 10.1016/j.bbadis.2015.08.007. Epub 2015 Aug 15.

Congenital Short Bowel Syndrome (CSBS) is a rare gastrointestinal disorder in which the mean length of the small intestine is substantially reduced when compared to its normal counterpart. Families with several affected members have been described and CSBS has...

Cite
van der Werf CS, Halim D, Verheij JB, et al. Congenital Short Bowel Syndrome: from clinical and genetic diagnosis to the molecular mechanisms involved in intestinal elongation. Biochim Biophys Acta. 2015;1852(11):2352-61doi: 10.1016/j.bbadis.2015.08.007.
van der Werf, C. S., Halim, D., Verheij, J. B., Alves, M. M., & Hofstra, R. M. (2015). Congenital Short Bowel Syndrome: from clinical and genetic diagnosis to the molecular mechanisms involved in intestinal elongation. Biochimica et biophysica acta, 1852(11), 2352-61. https://doi.org/10.1016/j.bbadis.2015.08.007
van der Werf, Christine S, et al. "Congenital Short Bowel Syndrome: from clinical and genetic diagnosis to the molecular mechanisms involved in intestinal elongation." Biochimica et biophysica acta vol. 1852,11 (2015): 2352-61. doi: https://doi.org/10.1016/j.bbadis.2015.08.007
van der Werf CS, Halim D, Verheij JB, Alves MM, Hofstra RM. Congenital Short Bowel Syndrome: from clinical and genetic diagnosis to the molecular mechanisms involved in intestinal elongation. Biochim Biophys Acta. 2015 Nov;1852(11):2352-61. doi: 10.1016/j.bbadis.2015.08.007. Epub 2015 Aug 15. PMID: 26282049.
Copy Download .nbib Format: NLM
Russell bodies in a skin biopsy: a case report.

Journal of medical case reports

Verheij J, Jaspars EH, Valk Pv, Rozendaal L.
PMID: 19946586
J Med Case Rep. 2009 Nov 04;3:108. doi: 10.1186/1752-1947-3-108.

INTRODUCTION: The presence of eosinophilic bodies in a skin biopsy can be found in a variety of situations and this may present a challenge to the pathologist. The differential diagnosis of these eosinophilic structures include microorganisms such as histoplasmosis...

Cite
Verheij J, Jaspars EH, Valk Pv, et al. Russell bodies in a skin biopsy: a case report. J Med Case Rep. 2009;3:108doi: 10.1186/1752-1947-3-108.
Verheij, J., Jaspars, E. H., Valk, P. v., & Rozendaal, L. (2009). Russell bodies in a skin biopsy: a case report. Journal of medical case reports, 3108. https://doi.org/10.1186/1752-1947-3-108
Verheij, Joanne, et al. "Russell bodies in a skin biopsy: a case report." Journal of medical case reports vol. 3 (2009): 108. doi: https://doi.org/10.1186/1752-1947-3-108
Verheij J, Jaspars EH, Valk Pv, Rozendaal L. Russell bodies in a skin biopsy: a case report. J Med Case Rep. 2009 Nov 04;3:108. doi: 10.1186/1752-1947-3-108. PMID: 19946586; PMCID: PMC2783049.
Copy Download .nbib Format: NLM
Maternal care affects the phenotype of a rat model for schizophrenia.

Frontiers in behavioral neuroscience

van Vugt RW, Meyer F, van Hulten JA, Vernooij J, Cools AR, Verheij MM, Martens GJ.
PMID: 25157221
Front Behav Neurosci. 2014 Aug 11;8:268. doi: 10.3389/fnbeh.2014.00268. eCollection 2014.

Schizophrenia is a complex mental disorder caused by an interplay between genetic and environmental factors, including early postnatal stressors. To explore this issue, we use two rat lines, apomorphine-susceptible (APO-SUS) rats that display schizophrenia-relevant features and their phenotypic counterpart,...

Cite
van Vugt RW, Meyer F, van Hulten JA, et al. Maternal care affects the phenotype of a rat model for schizophrenia. Front Behav Neurosci. 2014;8:268doi: 10.3389/fnbeh.2014.00268.
van Vugt, R. W., Meyer, F., van Hulten, J. A., Vernooij, J., Cools, A. R., Verheij, M. M., & Martens, G. J. (2014). Maternal care affects the phenotype of a rat model for schizophrenia. Frontiers in behavioral neuroscience, 8268. https://doi.org/10.3389/fnbeh.2014.00268
van Vugt, Ruben W M, et al. "Maternal care affects the phenotype of a rat model for schizophrenia." Frontiers in behavioral neuroscience vol. 8 (2014): 268. doi: https://doi.org/10.3389/fnbeh.2014.00268
van Vugt RW, Meyer F, van Hulten JA, Vernooij J, Cools AR, Verheij MM, Martens GJ. Maternal care affects the phenotype of a rat model for schizophrenia. Front Behav Neurosci. 2014 Aug 11;8:268. doi: 10.3389/fnbeh.2014.00268. eCollection 2014. PMID: 25157221; PMCID: PMC4128220.
Copy Download .nbib Format: NLM
Radionuclide Imaging of Apoptosis in Malignancies: Promise and Pitfalls of Tc-Hynic-rh-Annexin V Imaging.

Clinical medicine. Oncology

Kartachova MS, Verheij M, van Eck BL, Hoefnagel CA, Olmos RA.
PMID: 21892293
Clin Med Oncol. 2008;2:319-25. doi: 10.4137/cmo.s349. Epub 2008 Mar 25.

Radionuclide detection of apoptosis with of (99m)Tc-Hynic-rh-Annexin V scintigraphy is an effective tool for in vivo visualisation and monitoring of apoptosis in various malignant tumour. Early therapy-induced increase of the tumour tracer uptake correlates with favourable outcome, whereas stable...

Cite
Kartachova MS, Verheij M, van Eck BL, et al. Radionuclide Imaging of Apoptosis in Malignancies: Promise and Pitfalls of Tc-Hynic-rh-Annexin V Imaging. Clin Med Oncol. 2008;2:319-25doi: 10.4137/cmo.s349.
Kartachova, M. S., Verheij, M., van Eck, B. L., Hoefnagel, C. A., & Olmos, R. A. (2008). Radionuclide Imaging of Apoptosis in Malignancies: Promise and Pitfalls of Tc-Hynic-rh-Annexin V Imaging. Clinical medicine. Oncology, 2319-25. https://doi.org/10.4137/cmo.s349
Kartachova, M S, et al. "Radionuclide Imaging of Apoptosis in Malignancies: Promise and Pitfalls of Tc-Hynic-rh-Annexin V Imaging." Clinical medicine. Oncology vol. 2 (2008): 319-25. doi: https://doi.org/10.4137/cmo.s349
Kartachova MS, Verheij M, van Eck BL, Hoefnagel CA, Olmos RA. Radionuclide Imaging of Apoptosis in Malignancies: Promise and Pitfalls of Tc-Hynic-rh-Annexin V Imaging. Clin Med Oncol. 2008;2:319-25. doi: 10.4137/cmo.s349. Epub 2008 Mar 25. PMID: 21892293; PMCID: PMC3161632.
Copy Download .nbib Format: NLM
Fanconi anemia and homologous recombination gene variants are associated with functional DNA repair defects .

Oncotarget

Verhagen CVM, Vossen DM, Borgmann K, Hageman F, Grénman R, Verwijs-Janssen M, Mout L, Kluin RJC, Nieuwland M, Severson TM, Velds A, Kerkhoven R, O'Connor MJ, van der Heijden M, van Velthuysen ML, Verheij M, Wreesmann VB, Wessels LFA, van den Brekel MWM, Vens C.
PMID: 29719599
Oncotarget. 2018 Apr 06;9(26):18198-18213. doi: 10.18632/oncotarget.24797. eCollection 2018 Apr 06.

Mutations in Fanconi Anemia or Homologous Recombination (FA/HR) genes can cause DNA repair defects and could therefore impact cancer treatment response and patient outcome. Their functional impact and clinical relevance in head and neck squamous cell carcinoma (HNSCC) is...

Cite
Verhagen CVM, Vossen DM, Borgmann K, et al. Fanconi anemia and homologous recombination gene variants are associated with functional DNA repair defects . Oncotarget. 2018;9(26):18198-18213doi: 10.18632/oncotarget.24797.
Verhagen, C. V. M., Vossen, D. M., Borgmann, K., Hageman, F., Grénman, R., Verwijs-Janssen, M., Mout, L., Kluin, R. J. C., Nieuwland, M., Severson, T. M., Velds, A., Kerkhoven, R., O'Connor, M. J., van der Heijden, M., van Velthuysen, M. L., Verheij, M., Wreesmann, V. B., Wessels, L. F. A., van den Brekel, M. W. M., & Vens, C. (2018). Fanconi anemia and homologous recombination gene variants are associated with functional DNA repair defects . Oncotarget, 9(26), 18198-18213. https://doi.org/10.18632/oncotarget.24797
Verhagen, Caroline V M, et al. "Fanconi anemia and homologous recombination gene variants are associated with functional DNA repair defects ." Oncotarget vol. 9,26 (2018): 18198-18213. doi: https://doi.org/10.18632/oncotarget.24797
Verhagen CVM, Vossen DM, Borgmann K, Hageman F, Grénman R, Verwijs-Janssen M, Mout L, Kluin RJC, Nieuwland M, Severson TM, Velds A, Kerkhoven R, O'Connor MJ, van der Heijden M, van Velthuysen ML, Verheij M, Wreesmann VB, Wessels LFA, van den Brekel MWM, Vens C. Fanconi anemia and homologous recombination gene variants are associated with functional DNA repair defects . Oncotarget. 2018 Apr 06;9(26):18198-18213. doi: 10.18632/oncotarget.24797. eCollection 2018 Apr 06. PMID: 29719599; PMCID: PMC5915066.
Copy Download .nbib Format: NLM
A trial like ALIC.

ERJ open research

Butler CC, Coenen S, Saville BR, Cook J, van der Velden A, Homes J, de Jong M, Little P, Goossens H, Beutels P, Ieven M, Francis N, Moons P, Bongard E, Verheij T.
PMID: 29761108
ERJ Open Res. 2018 May 08;4(2). doi: 10.1183/23120541.00046-2018. eCollection 2018 Apr.

ALIC

Cite
Butler CC, Coenen S, Saville BR, et al. A trial like ALIC. ERJ Open Res. 2018;4(2)doi: 10.1183/23120541.00046-2018.
Butler, C. C., Coenen, S., Saville, B. R., Cook, J., van der Velden, A., Homes, J., de Jong, M., Little, P., Goossens, H., Beutels, P., Ieven, M., Francis, N., Moons, P., Bongard, E., & Verheij, T. (2018). A trial like ALIC. ERJ open research, 4(2), . https://doi.org/10.1183/23120541.00046-2018
Butler, Christopher C, et al. "A trial like ALIC." ERJ open research vol. 4,2 (2018). doi: https://doi.org/10.1183/23120541.00046-2018
Butler CC, Coenen S, Saville BR, Cook J, van der Velden A, Homes J, de Jong M, Little P, Goossens H, Beutels P, Ieven M, Francis N, Moons P, Bongard E, Verheij T. A trial like ALIC. ERJ Open Res. 2018 May 08;4(2). doi: 10.1183/23120541.00046-2018. eCollection 2018 Apr. PMID: 29761108; PMCID: PMC5938489.
Copy Download .nbib Format: NLM
Genetic Factors Associated with a Poor Outcome in Head and Neck Cancer Patients Receiving Definitive Chemoradiotherapy.

Cancers

Vossen DM, Verhagen CVM, van der Heijden M, Essers PBM, Bartelink H, Verheij M, Wessels LFA, van den Brekel MWM, Vens C.
PMID: 30934880
Cancers (Basel). 2019 Mar 29;11(4). doi: 10.3390/cancers11040445.

About half of advanced stage head and neck squamous cell carcinoma (HNSCC) patients can be cured by chemoradiotherapy. Patient outcome may be partially determined by the genetic alterations in HNSCC, rendering these alterations promising candidate prognostic factors and/or therapeutic...

Cite
Vossen DM, Verhagen CVM, van der Heijden M, et al. Genetic Factors Associated with a Poor Outcome in Head and Neck Cancer Patients Receiving Definitive Chemoradiotherapy. Cancers (Basel). 2019;11(4)doi: 10.3390/cancers11040445.
Vossen, D. M., Verhagen, C. V. M., van der Heijden, M., Essers, P. B. M., Bartelink, H., Verheij, M., Wessels, L. F. A., van den Brekel, M. W. M., & Vens, C. (2019). Genetic Factors Associated with a Poor Outcome in Head and Neck Cancer Patients Receiving Definitive Chemoradiotherapy. Cancers, 11(4), . https://doi.org/10.3390/cancers11040445
Vossen, David M, et al. "Genetic Factors Associated with a Poor Outcome in Head and Neck Cancer Patients Receiving Definitive Chemoradiotherapy." Cancers vol. 11,4 (2019). doi: https://doi.org/10.3390/cancers11040445
Vossen DM, Verhagen CVM, van der Heijden M, Essers PBM, Bartelink H, Verheij M, Wessels LFA, van den Brekel MWM, Vens C. Genetic Factors Associated with a Poor Outcome in Head and Neck Cancer Patients Receiving Definitive Chemoradiotherapy. Cancers (Basel). 2019 Mar 29;11(4). doi: 10.3390/cancers11040445. PMID: 30934880; PMCID: PMC6521057.
Copy Download .nbib Format: NLM
Noradrenaline-induced release of newly-synthesized accumbal dopamine: differential role of alpha- and beta-adrenoceptors.

Frontiers in cellular neuroscience

Meyer F, Latour J, Cools AR, Verheij MM.
PMID: 25309315
Front Cell Neurosci. 2014 Aug 21;8:243. doi: 10.3389/fncel.2014.00243. eCollection 2014.

Previous studies have shown that intra-accumbens infusion of isoproterenol (ISO), a beta-adrenoceptor-agonist, and phenylephrine (PE), an alpha-adrenoceptor-agonist, increase the release of accumbal dopamine (DA). In the present study we analyzed whether the ISO-induced release of DA is sensitive to...

Cite
Meyer F, Latour J, Cools AR, et al. Noradrenaline-induced release of newly-synthesized accumbal dopamine: differential role of alpha- and beta-adrenoceptors. Front Cell Neurosci. 2014;8:243doi: 10.3389/fncel.2014.00243.
Meyer, F., Latour, J., Cools, A. R., & Verheij, M. M. (2014). Noradrenaline-induced release of newly-synthesized accumbal dopamine: differential role of alpha- and beta-adrenoceptors. Frontiers in cellular neuroscience, 8243. https://doi.org/10.3389/fncel.2014.00243
Meyer, Francisca, et al. "Noradrenaline-induced release of newly-synthesized accumbal dopamine: differential role of alpha- and beta-adrenoceptors." Frontiers in cellular neuroscience vol. 8 (2014): 243. doi: https://doi.org/10.3389/fncel.2014.00243
Meyer F, Latour J, Cools AR, Verheij MM. Noradrenaline-induced release of newly-synthesized accumbal dopamine: differential role of alpha- and beta-adrenoceptors. Front Cell Neurosci. 2014 Aug 21;8:243. doi: 10.3389/fncel.2014.00243. eCollection 2014. PMID: 25309315; PMCID: PMC4162431.
Copy Download .nbib Format: NLM
Practice-Level Association between Antibiotic Prescribing and Resistance: An Observational Study in Primary Care.

Antibiotics (Basel, Switzerland)

Batenburg D, Verheij T, Van't Veen A, van der Velden A.
PMID: 32752214
Antibiotics (Basel). 2020 Aug 01;9(8). doi: 10.3390/antibiotics9080470.

A direct relation between antibiotic use and resistance has been shown at country level. We aim to investigate the association between antibiotic prescribing for patients from individual Dutch primary care practices and antibiotic resistance of bacterial isolates from routinely...

Cite
Batenburg D, Verheij T, Van't Veen A, et al. Practice-Level Association between Antibiotic Prescribing and Resistance: An Observational Study in Primary Care. Antibiotics (Basel). 2020;9(8)doi: 10.3390/antibiotics9080470.
Batenburg, D., Verheij, T., Van't Veen, A., & van der Velden, A. (2020). Practice-Level Association between Antibiotic Prescribing and Resistance: An Observational Study in Primary Care. Antibiotics (Basel, Switzerland), 9(8), . https://doi.org/10.3390/antibiotics9080470
Batenburg, Dylan, et al. "Practice-Level Association between Antibiotic Prescribing and Resistance: An Observational Study in Primary Care." Antibiotics (Basel, Switzerland) vol. 9,8 (2020). doi: https://doi.org/10.3390/antibiotics9080470
Batenburg D, Verheij T, Van't Veen A, van der Velden A. Practice-Level Association between Antibiotic Prescribing and Resistance: An Observational Study in Primary Care. Antibiotics (Basel). 2020 Aug 01;9(8). doi: 10.3390/antibiotics9080470. PMID: 32752214; PMCID: PMC7460110.
Copy Download .nbib Format: NLM
Biological Determinants of Chemo-Radiotherapy Response in HPV-Negative Head and Neck Cancer: A Multicentric External Validation.

Frontiers in oncology

van der Heijden M, Essers PBM, de Jong MC, de Roest RH, Sanduleanu S, Verhagen CVM, Hamming-Vrieze O, Hoebers F, Lambin P, Bartelink H, Leemans CR, Verheij M, Brakenhoff RH, van den Brekel MWM, Vens C.
PMID: 31998639
Front Oncol. 2020 Jan 10;9:1470. doi: 10.3389/fonc.2019.01470. eCollection 2019.

No abstract available.

Cite
van der Heijden M, Essers PBM, de Jong MC, et al. Biological Determinants of Chemo-Radiotherapy Response in HPV-Negative Head and Neck Cancer: A Multicentric External Validation. Front Oncol. 2020;9:1470doi: 10.3389/fonc.2019.01470.
van der Heijden, M., Essers, P. B. M., de Jong, M. C., de Roest, R. H., Sanduleanu, S., Verhagen, C. V. M., Hamming-Vrieze, O., Hoebers, F., Lambin, P., Bartelink, H., Leemans, C. R., Verheij, M., Brakenhoff, R. H., van den Brekel, M. W. M., & Vens, C. (2019). Biological Determinants of Chemo-Radiotherapy Response in HPV-Negative Head and Neck Cancer: A Multicentric External Validation. Frontiers in oncology, 91470. https://doi.org/10.3389/fonc.2019.01470
van der Heijden, Martijn, et al. "Biological Determinants of Chemo-Radiotherapy Response in HPV-Negative Head and Neck Cancer: A Multicentric External Validation." Frontiers in oncology vol. 9 (2019): 1470. doi: https://doi.org/10.3389/fonc.2019.01470
van der Heijden M, Essers PBM, de Jong MC, de Roest RH, Sanduleanu S, Verhagen CVM, Hamming-Vrieze O, Hoebers F, Lambin P, Bartelink H, Leemans CR, Verheij M, Brakenhoff RH, van den Brekel MWM, Vens C. Biological Determinants of Chemo-Radiotherapy Response in HPV-Negative Head and Neck Cancer: A Multicentric External Validation. Front Oncol. 2020 Jan 10;9:1470. doi: 10.3389/fonc.2019.01470. eCollection 2019. PMID: 31998639; PMCID: PMC6966332.
Copy Download .nbib Format: NLM
Does C-reactive protein predict time to recovery and benefit from oseltamivir treatment in primary care patients with influenza-like illness? A randomized controlled trial secondary analysis.

Scandinavian journal of primary health care

Harbin NJ, Rystedt K, Lindbaek M, Radzeviciene R, Westin J, Gunnarsson R, Butler CC, van der Velden AW, Verheij TJ, Sundvall PD.
PMID: 34850657
Scand J Prim Health Care. 2021 Dec 01;1-6. doi: 10.1080/02813432.2021.2006482. Epub 2021 Dec 01.

OBJECTIVE: Recovery time and treatment effect of oseltamivir in influenza-like illness (ILI) differs between patient groups. A point-of-care test to better predict ILI duration and identify patients who are most likely to benefit from oseltamivir treatment would aid prescribing...

Cite
Harbin NJ, Rystedt K, Lindbaek M, et al. Does C-reactive protein predict time to recovery and benefit from oseltamivir treatment in primary care patients with influenza-like illness? A randomized controlled trial secondary analysis. Scand J Prim Health Care. 2021;1-6doi: 10.1080/02813432.2021.2006482.
Harbin, N. J., Rystedt, K., Lindbaek, M., Radzeviciene, R., Westin, J., Gunnarsson, R., Butler, C. C., van der Velden, A. W., Verheij, T. J., & Sundvall, P. D. (2021). Does C-reactive protein predict time to recovery and benefit from oseltamivir treatment in primary care patients with influenza-like illness? A randomized controlled trial secondary analysis. Scandinavian journal of primary health care, 1-6. https://doi.org/10.1080/02813432.2021.2006482
Harbin, Nicolay Jonassen, et al. "Does C-reactive protein predict time to recovery and benefit from oseltamivir treatment in primary care patients with influenza-like illness? A randomized controlled trial secondary analysis." Scandinavian journal of primary health care vol. (2021): 1-6. doi: https://doi.org/10.1080/02813432.2021.2006482
Harbin NJ, Rystedt K, Lindbaek M, Radzeviciene R, Westin J, Gunnarsson R, Butler CC, van der Velden AW, Verheij TJ, Sundvall PD. Does C-reactive protein predict time to recovery and benefit from oseltamivir treatment in primary care patients with influenza-like illness? A randomized controlled trial secondary analysis. Scand J Prim Health Care. 2021 Dec 01;1-6. doi: 10.1080/02813432.2021.2006482. Epub 2021 Dec 01. PMID: 34850657.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 140 entries